The landscape of dementia diagnosis has progressed radically with the appearance of innovative biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not dim... https://theoj429kue0.bloggazza.com/profile